Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Neutral

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Cryo-Cell International Inc. (CCEL)

Services-misc Health & Allied Services, Nec

https://www.cryo-cell.com

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.

700 BROOKER CREEK BLVD, SUITE 1800
OLDSMAR, FL

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/01/1970

Market Cap

53,369,050

Shares Outstanding

8,289,999

Weighted SO

8,286,785

Total Employees

N/A

Upcoming Earnings

10/10/2024

Similar Tickers

NHC --.--%

INNV --.--%

PNTG --.--%

EHC --.--%

AIH --.--%

AIRS --.--%

AVAH --.--%

TOI --.--%

BKD --.--%

Beta

0.5550

Last Div

0.0000

Range

3.67-9.5

Chg

-0.1250

Avg Vol

6027

Mkt Cap

53369050

Exch

NASDAQ

Country

US

Phone

813 749 2100

DCF Diff

4.5774

DCF

2.0426

Div Yield

0.0000

P/S

2.2615

EV Multiple

15.5593

P/FV

0.0000

Div Yield %

0.0000

P/E

-5.7798

PEG

0.0130

Payout

0.0000

Current Ratio

0.0000

Quick Ratio

0.0000

Cash Ratio

0.0000

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.7291

Op Margin

-0.5737

Pretax Margin

-0.5710

Net Margin

-0.3940

Eff Tax Rate

0.3100

ROA

-0.1486

ROE

1.7390

ROCE

-0.2164

NI/EBT

0.6900

EBT/EBIT

0.9954

EBIT/Rev

-0.5737

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

-24.3023

CF/Debt

0.0000

Equity Multi

0.0000

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.3772

OCF/Share

0.6073

FCF/Share

-0.1150

Cash/Share

0.0000

OCF/Sales

0.2089

FCF/OCF

-0.1894

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.8408

Div&CapEx Cov

0.8408

P/BV

0.0000

P/B

0.0000

P/S

2.2615

P/E

-5.7798

P/FCF

-57.1535

P/OCF

10.9004

P/CF

10.9004

PEG

0.0130

P/S

2.2615

EV Multiple

15.5593

P/FV

0.0000

DPS

0.0000

Latest Headlines (EST)

Benzinga Dec 16, 00:30 Stem Cell Banking Market to Surpass Value of USD 18.65 Billion By 2031 | SkyQuest Technology GlobeNewswire Inc. Dec 16, 00:30 Stem Cell Banking Market to Surpass Value of USD 18.65 Billion By 2031 | SkyQuest Technology

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.90 09/01/2022 08/22/2022 09/02/2022 09/09/2022